￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the prospects for medical insurance inclusion of serputinib/serpatinib in 2025

2026-02-01 22:25:32

Check Details
Targets and mechanisms of action of lenvatinib/lenvatinib (Lenvima)

2026-02-01 22:25:32

Check Details
Storage conditions requirements for fezolinetant

2026-02-01 22:25:32

Check Details
Advantages and side effects of tucatinib/tucatinib

2026-02-01 22:25:32

Check Details
How generic prices for Alpelisib compare

2026-02-01 22:25:32

Check Details
How patients should monitor their health while taking fostatinib/fotantinib

2026-02-01 22:25:32

Check Details
Description of efficacy, effects and side effects of Serputinib/Serpatinib (Ruitu)

2026-02-01 22:25:32

Check Details
Lenvatinib/Lenvatinib (Lenvima) efficacy and side effects description

2026-02-01 22:25:32

Check Details
What are the precautions for taking fezolinetant?

2026-02-01 22:25:32

Check Details
Comparison of safety and efficacy of platinib (Pujihua) combined with chemotherapy

2026-02-01 22:25:32

Check Details
What issues should patients with diabetes pay attention to when using capmatinib (Touradida)?

2026-02-01 22:25:32

Check Details
Therapeutic efficacy and safety of sotoracib (AMG 510) in elderly patients with lung cancer

2026-02-01 22:25:32

Check Details
Category
相关知识